Search Results - "WATT, K. D. S"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Evolution of Causes and Risk Factors for Mortality Post‐Liver Transplant: Results of the NIDDK Long‐Term Follow‐Up Study by Watt, K. D. S., Pedersen, R. A., Kremers, W. K., Heimbach, J. K., Charlton, M. R.

    Published in American journal of transplantation (01-06-2010)
    “…Although mortality rates following liver transplantation (LT) are well described, there is a lack of detailed, prospective studies determining patterns of and…”
    Get full text
    Journal Article
  2. 2

    Combined Liver Transplantation and Gastric Sleeve Resection for Patients With Medically Complicated Obesity and End‐Stage Liver Disease by Heimbach, J. K., Watt, K. D. S., Poterucha, J. J., Ziller, N. Francisco, Cecco, S. D., Charlton, M. R., Hay, J. E., Wiesner, R. H., Sanchez, W., Rosen, C. B., Swain, J. M.

    Published in American journal of transplantation (01-02-2013)
    “…Obesity is increasingly common before and after liver transplantation (LT), yet optimal management remains unclear. Our aim was to analyze the effectiveness of…”
    Get full text
    Journal Article
  3. 3

    Insulin Resistance, Serum Adipokines and Risk of Fibrosis Progression in Patients Transplanted for Hepatitis C by Veldt, B. J., Poterucha, J. J., Watt, K. D. S., Wiesner, R. H., Hay, J. E., Rosen, C. B., Heimbach, J. K., Janssen, H. L. A., Charlton, M. R.

    Published in American journal of transplantation (01-06-2009)
    “…In the nontransplant setting diabetes mellitus is a risk factor for disease progression in patients with chronic hepatitis C virus (HCV) infection. The impact…”
    Get full text
    Journal Article
  4. 4

    Impact of Pegylated Interferon and Ribavirin Treatment on Graft Survival in Liver Transplant Patients with Recurrent Hepatitis C Infection by Veldt, B. J., Poterucha, J. J., Watt, K. D. S., Wiesner, R. H., Hay, J. E., Kremers, W. K., Rosen, C. B., Heimbach, J. K., Charlton, M. R.

    Published in American journal of transplantation (01-11-2008)
    “…Recurrent hepatitis C virus (HCV) infection is a major cause of morbidity and mortality after liver transplantation for HCV‐related end stage liver disease…”
    Get full text
    Journal Article
  5. 5

    Mortality While Awaiting Liver Retransplantation: Predictability of MELD Scores by Watt, K.D.S., Menke, T., Lyden, E., McCashland, T.M.

    Published in Transplantation proceedings (01-06-2005)
    “…Model for End-stage Liver Disease (MELD) scores at the time of listing on the transplant waiting list have been shown to accurately predict 3-month mortality…”
    Get full text
    Journal Article
  6. 6